@inproceedings{inproceedings, title  = {{Efficacy and safety of dupilumab in children aged 6-11 years with inadequately controlled severe atopic dermatitis: results from an open-label extension trial up to 1 year}},

 url = {{}},

 year = {{2022}},

 month = {{1}},

 author = {{Paller AS and Cork MJ and Siegfried EC and Guttman-Yassky E and Simpson EL and Soong W and Xiao J and Wang Z and Chuang C-C and O'Malley JT and Bansal A}},

 volume = {{186}},

 journal = {{BRITISH JOURNAL OF DERMATOLOGY}},

 issue = {{4}},

 pages = {{E159-E160}},

 note = {{Accessed on 2024/12/22}}}